We spotlight Co-Founder and CEO, Christopher Dawson along with Co-Founder and COO, Andrew Galloway
Similar Posts
Interview With Joshua White
Fireside Project’s Co-Founder and Director, Joshua White, speaks about the creation and the future of the organization.
Interview With Daniel Carcillo
In this episode of the Psychedelic Spotlight podcast we catch up with Daniel Carcillo, Founder and CEO of Wesana Health.
Interview With Rabbi Zac Kamenetz
Founder and CEO of Shefa, and Co-Founder of the Jewish Psychedelic Summit, Rabbi Zac Kamenetz, speaks about the upcoming summit and the connection between Judaism and psychedelics.
Interview with Trevor Millar, Advisor, NeonMind Biosciences
In our conversation with Trevor, we have the opportunity to discuss some of the psychedelic-based treatments NeonMind is currently focused on developing to help tackle obesity. Obesity is one of the more prevalent health conditions today affecting millions of individuals worldwide. The World Health Organization has claimed that obesity has reached epidemic proportions globally with at least 2.8 million people dying each year as a result of being overweight or obese.
Psychedelic Business Roundup- Mike Tyson’s New Investment
May 26, 2021-This week’s Psychedelic Business News Round Up’s top…